These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15573801)
21. Lessons on prescribing and drug safety from the withdrawal of rofecoxib. Nelson M; Cicuttini F Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913 [No Abstract] [Full Text] [Related]
22. Drug safety: are we making progress?: comment on "pooled analysis of rofecoxib placebo-controlled clinical trial data". Luepker RV Arch Intern Med; 2010 Jan; 170(2):202. PubMed ID: 20101016 [No Abstract] [Full Text] [Related]
23. The Vioxx debacle. Fielder JH IEEE Eng Med Biol Mag; 2005; 24(2):106-9. PubMed ID: 15825852 [No Abstract] [Full Text] [Related]
29. What is a 'safe' drug? Healy B US News World Rep; 2004 Dec; 137(21):37. PubMed ID: 15636504 [No Abstract] [Full Text] [Related]
30. Is concern about cardiovascular events with the new coxib class of drugs justified? Schnitzer TJ Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930 [No Abstract] [Full Text] [Related]
31. Celecoxib shown effective in preventing colon polyps. Nelson NJ J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118 [No Abstract] [Full Text] [Related]
32. Bringing the FDA's Information to Market. Woloshin S; Schwartz LM Arch Intern Med; 2009 Nov; 169(21):1985-7. PubMed ID: 19933960 [No Abstract] [Full Text] [Related]